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Abstract: We applied the wide-field Mueller imaging polarimetry for the screening of formalin-
fixed paraffin-embedded samples of mouse brain tissue at different stages of brain β-amyloidosis
in Alzheimer’s disease (AD). The accumulation of amyloid-beta (Aβ) deposits throughout
the brain tissue is one of the key pathological hallmarks observed with the AD progression.
We demonstrate that the presence of Aβ plaques influences the properties of backscattered
polarized light, in particular, its degree of depolarization. By means of statistical analysis, we
demonstrate that the high-order statistical moments of depolarization distributions, acquired
with the multi-spectral Mueller imaging polarimetry, can be used as sensitive markers of the
growing presence of Aβ plaques. The introduced label-free polarimetric approach has a potential
to facilitate the current practice of the histopathology screening in terms of diagnosis accuracy,
time and cost efficiency.
© 2020 Optical Society of America under the terms of the OSA Open Access Publishing Agreement
1. Introduction
Due to the ongoing aging of the population, dementia has become one of the major social and
financial burdens in the modern world [1,2]. In 2015, the total number of people with dementia
worldwide was estimated at 46M and was predicted to raise up to 115.4M by the year 2050 [2].
The Alzheimer’s disease (AD) is the most frequent cause of dementia [2]; therefore, there is a
growing demand for the improving of diagnosis and treatment of AD.
The major hallmarks of the AD are the accumulation of extracellular senile plaques composed
of amyloid-beta (Aβ) and intracellular neurofibrillary tangles composed of hyperphosphorylated
tau protein accompanied by neuronal cell losses throughout grey matter and hippocampi [3].
Clinical diagnostics of AD is performed with the use of computed tomography (CT), magnetic
resonance imaging (MRI), positron emission tomography (PET), and single-photon emission
computed tomography (SPECT) [1]. However, these techniques are restricted by the spatial
resolution of minimum 100-200 µm [4,5], which limits their accuracy. Therefore, in order to
assess a detailed structure of brain tissue, there is a need for the histological analysis, which
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currently is the only technique that provides definite diagnosis of AD (post mortem). Standard
routine procedure of histological analysis implies laborious sample preparation, which includes
fixation of the brain in 4% formalin for 1–3 weeks (depending on the brain size), sectioning and
processing of the fixed tissue, dehydration, embedding in paraffin, thin sectioning of the obtained
formalin-fixed paraffin-embedded (FFPE) tissue block with a microtome, mounting the acquired
thin brain slices on a glass slide, staining, and finally microscopic investigation of the thin tissue
sections. This protocol is very costly and time-consuming, depends strongly on the pathologist
skills and provides only qualitative information. Thus, there is a need for a new label-free and
less labor-intensive technique, which in the future could be enhanced with machine learning
algorithms to improve the diagnosis accuracy.
Among the cutting-edge research, a number of techniques based on optical microscopy have
shown promising results in label-free visualization of senile plaques in thin slices of fixed brain
tissue. The examples are optical coherence microscopy (OCM) [6], polarization-sensitive optical
coherence microscopy (PS-OCM) [7], diffraction phase microscopy (DPM) [8], multiphoton
microscopy [9], cryo-micro-optical sectioning tomography (cryo-MOST) [10], stimulated Raman
scattering (SRS) microscopy [11]. It has been shown that the structural changes, in particular, Aβ
plaques are mostly observed in the grey matter and hippocampi, whereas the changes in the white
matter are minor [8]. Moreover, it has been demonstrated that the brain tissue with AD exhibits
higher inhomogeneity of refractive index, higher scattering coefficient, higher birefringence due
to parallel alignment of fibrils in Aβ plaques and higher anisotropy of scattering [7,8]. Though the
abovementioned techniques allow label-free imaging of brain tissue with sub-micron resolution,
they require sectioning the FFPE tissue block into thin slices. In the current study, we examine
the bulk mouse brain tissue in the FFPE block (without cutting it in thin sections) by using optical
wide-field imaging Mueller polarimetric technique.
The use of imaging and characterization techniques based on polarization of light in biomedical
research has been growing during the past several years [12]. In particular, imaging Mueller
matrix (MM) polarimetry is a powerful approach, which has shown very promising results in
functional characterization of various types of tissues. The technique is based on measuring the
4 × 4 MM of a sample. All elements of MM are real numbers, MM contains full information
on polarimetric properties of the sample in the absence of non-linear effects. In the recently
published studies, MM polarimetry has been applied to differentiating the polycrystalline structure
of healthy and pathologically altered tissues of myocardium [13], characterization of rectum
wall tissue, vaginal wall during genital prolapse, brain tissue [14], detection of healthy and
pre-cancerous regions of uterine cervix tissue [15–17], blood films characterization for cancer
diagnosis [18], detection of cancer of colorectal tissue [19,20] and characterization of other
tissues [21,22]. Other polarization-based techniques, such as Stokes polarimetry based on
circularly polarized illumination [23,24], Jones-matrix tomography [25,26], Stokes correlometry
[27] were also widely used for the characterization of various tissues.
In this study, we used MM polarimetry to investigate the possibility of express screening of
brain tissue in FFPE blocks with progressing structural malformations caused by AD. The aim of
this study was the proof of concept of possibility to develop a fast label-free cost-effective express
screening technique for pathology analysis and quantitative scoring of FFPE brain tissue blocks
with AD based on the wide-field imaging MM polarimetry operating in the visible spectrum
range. To enhance the diagnostic accuracy of MM polarimetry, we applied statistical analysis of
polarimetric parameters. This approach was also used in previous studies [13,14,18,20,28].
2. Method and materials
The multi-wavelength liquid-crystal-based imaging MM system operating in backscattering
geometry [29,30] was developed in the LPICM, Ecole polytechnique, France. The schematic of
the setup is shown in Fig. 1. The polarization of the light emitted by the halogen light source is
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modulated by the Polarization State Generator (PSG), which consists of a linear polarizer and
two electrically driven liquid crystals. The polarization state of incident light beam is changed
due to the interaction with a sample. Light, backscattered from a sample, passes through the
polarization state analyzer (PSA), which consists of the same optical components as PSG, but
assembled in a reversed order. A spectral wheel with 6 bandpass filters (20 nm bandwidth
centered at 450–550 nm with a 50 nm step) is placed in front of the CCD camera. During the
measurements, four different polarization states of light are sequentially generated by PSG. For
each polarization state of the illuminating beam, the PSA, modulated sequentially to one of
the same four polarization states, transmits the backscattered light, thus, forming 16 different
intensity images on the CCD camera. These 16 raw intensity images are processed using the
calibration data of the system obtained prior to measurements to get a MM of a sample. The
light incidence angle is about 15° from normal; the CCD camera is placed at normal to the
sample measurement plane. The measured samples were covered with index matching liquid
(refractive oil) in order to flatten the top surface and reduce the artifacts associated with specular
reflection. The elements of MM were normalized by m11, representing dimensionless quantities
varying from -1 to 1. The interpretation of the MM of mouse brain samples was performed using
Lu-Chipman decomposition algorithm [31] that represents any physically realizable MM as a
product of three matrices of basic optical elements, namely, diattenuator, retarder and depolarizer.
Fig. 1. Schematic presentation of the custom-built MM imaging polarimeter [29,30].
Further details are given in the text.
In the current study, we investigated 21 FFPE mouse brain tissue specimens. All protocols
involving the breeding and use of animals were approved by the Norwegian Food Safety
(Mattilsynet). All study procedureswere performed in accordancewith theEuropeanCommunities
Council Directive of September 22, 2010 (2010/63/EU). The brain hemispheres were excised
from sacrificed APP-transgenic mice (APPPS-21, APPtg) [32] at different ages: 50, 75, 100, 125,
150, 175, and 200 days (3 samples per each AD stage). The stage of the β-amyloidosis correlates
with the age of animals. The animals start with Aβ deposition at an age of 45 days. Figures 2(a,
a-1), 2(b, b-1), 2(c, c-1) show histological images of the brain cuts of mice of different age,
obtained with the help of immunohistochemistry (IHC) techniques [33–36] and a conventional
optical microscope. Figures 2(a, a-1) show the histology images of a 50-days old mouse, while
Figs. 2(b, b-1) and 2(c, c-1) show the histology images of a 125-days old and 200-days old mice,
respectively. Figures 2(a-1), 2(b-1), 2(c-1) show magnified images from Figs. 2(a), 2(b), 2(c).
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Aβ plaques are observed in Figs. 2(b, b-1) and 2(c, c-1) as dark brown spots throughout the brain
tissue due to IHC staining. The increased amount of Aβ plaques correlates with a more advanced
AD stage. Each of the FFPE blocks contains two mouse brain hemispheres [see a photograph of
a FFPE block in Fig. 2(d)].
Fig. 2. Images of mouse brain specimens: (a, a-1) Histological images of the brain slices of
a 50-day-old, (b, b-1) a 125-day-old, and (c, c-1) a 200-day-old mouse with AD. Panels (a-1,
b-1, c-1) show magnified images in (a, b, c). (d) A photograph of a FFPE block. Scale bars:
(a, b, c) 1 mm, (a-1, b-1, c-1) 500 µm, (d) 5 mm.
3. Mueller matrix imaging of brain tissue with AD
The MM images of one FFPE brain sample of a 75-days old mouse obtained with the wide-field
MM polarimeter at 450, 500, and 550 nm central wavelength are shown in Figs. 3(a)–3(d). For
all FFPE brain samples screened in the current study, the corresponding MM demonstrated
similar structure as shown in Fig. 3. As it was shown in Fig. 2(d), each FFPE tissue block
contained the brain tissue and surrounding paraffin. For the analysis of the obtained MMs of
FFPE blocks, the regions containing brain tissue were selected from the images based on the
spatial distribution of non-normalized m11 element (total intensity image) taken at 450 nm. The
selection was performed using polynomial region of interest (ROI) selection toolbox in MATLAB.
The ROIs selected at 450 nm were transformed to the MM results taken at other wavelengths with
consideration of the slight shifts in spatial coordinates, imposed by the wavelength difference.
As one can see in Fig. 3, the only non-zero elements of the MM are located at the main diagonal
of the matrices. The values of off-diagonal elements did not exceed 0.02. The diagonal structure
of MM was observed for all brain samples measured at 450-550 nm. The diagonal MM is an
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Fig. 3. 4 × 4 MM images of a FFPE mouse brain sample (75-days old) obtained at (a) 450
nm, (b) 500 nm, (c) 550 nm. Field of view: 12 mm × 14.5 mm (251 × 301 pixels). Refer to
Supplement 1 for high resolution images of m22, m33, m44 (Fig. S1-S3).
indicator that the sample acts as a partial depolarizer (for an ideal depolarizer, all MM elements
are equal to 0 except of m11) and does not possess any significant retardance or diattenuation.
Therefore, all examined samples of paraffin-embedded brain behave as partial depolarizers. Thus,
only the diagonal elements, m22, m33, and m44, which characterize the degree of depolarization
of linearly (0°-90°, ±45° frames) and circularly polarized light, respectively, contain relevant
information for the quantitative analysis. Refer to Supplement 1 for high resolution images of
m22, m33, m44 (Figs. S1-S3).
The results presented in Fig. 3 show that the values of diagonal elements of MM decrease at
each pixel of the image and the contrast between the brain tissue and paraffin in m22, m33, and
m44 images drops with the increase of the wavelength of incident light. A plot of wavelength
dependence of values of m22, m33, and m44 averaged over selected ROI of brain tissue is
presented in Fig. 4(a). The observed decrease in the averaged values of m22, m33, and m44 [see
Fig. 4(a)] correlates well with the absorbance of the FFPE brain tissue, which was measured
with a hyperspectral camera (SPECIM, Finland). Figure 4(b) shows the calculated absorbance
spectrum of the FFPE brain tissue. Here, the absorbance spectrum is presented in terms of
log(1/R), where R is reflectance of the brain tissue, which was selected from the reflectance cube
of the whole tissue block using ROI selection and then averaged over the selected brain area. The
reflectance cube of the tissue block was calculated as a ratio between the acquired hyperspectral
reflection cubes of the tissue block and a reference sample (spectralon).
Fig. 4. (a) Averaged values of discrete components of m22, m33 and m44 elements of the
mouse brain sample (75-days old); (b) Absorbance spectrum of the same sample measured
with a hyperspectral camera (SPECIM, Finland).
The decrease in absorbance with the increase of the wavelength of incident illumination [see
Fig. 4(b)] enhances the penetration depth, which leads to the growing number of scattering
events. Thus, higher depolarization values were observed at 500 and 550 nm [37]. Therefore,
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due to higher preservation of the polarization of backscattered light, the results obtained at the
wavelength 450 nm were chosen for the further analysis.
According to results presented in Fig. 4(a), the values of m22 and m33 are larger than m44
value (m22=m33>m44) at 450 nm by approximately 8%. It means that the incident circularly
polarized light is more depolarized by the sample compared to the incident linearly polarized
light. This is a typical response for biological tissues that exhibit Rayleigh scattering rather than
Mie scattering when measured in backscattering configuration [37–39]. At longer wavelengths,
m22≈m33≈m44, which means that the sample exhibits scattering in the Rayleigh–Mie transition
regime and acts as an isotropic depolarizer [39].
4. Statistical analysis
As discussed in the previous section, m22, m33, m44 elements and total depolarization obtained
at 450 nm central wavelength were identified as the most relevant elements for the analysis. The
parameter of total depolarization of tissue is calculated as [40]:
∆ = 1 − |m22| + |m33| + |m44|
3
. (1)
The spatial distribution of total depolarization were analyzed for the ROI contained brain
tissue only (see Fig. 5).
Fig. 5. (a) Unpolarized total intensity image at 450 nm (m11 element) with black line
contours showing the selected ROI. (b) Map of total depolarization with the black ROI
contours transferred from (a). The total depolarization data inside the selected ROI were
used for the statistical analysis. Scale bar: 1 mm.
Statistical moments from 1st to 4th order (mean value (Z1), standard deviation (Z2), skewness
(Z3), kurtosis (Z4)) of the distributions of total depolarization (∆), and diagonal elements of
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Here, N is the total number of pixels in each analyzed ROI image, while index j stands for
pixel number.
The obtained statistical moments were averaged over the corresponding age group. Figure 6
shows the averaged values of the obtained 1st to 4th statistical moments of the distributions of
total depolarization of screened mouse brain samples plotted versus the animal’s age. Error bars
represent standard deviation of statistical moments.
Fig. 6. Statistical moments of the 1st - 4th orders characterizing the spatial distributions of
total depolarization of FFPE mouse brain with AD (50 to 200 days) measured at 450 nm:
(a) mean, (b) standard deviation, (c) skewness, (d) kurtosis. Red solid lines show fitting
functions: linear in (a, b), exponential in (c, d).
The obtained results have shown that the 1st and 2nd order statistical moments of depolarization
are not sensitive to the AD progression, whereas statistical moments of the higher orders show
exponential changes with the progression of the disease (see Fig. 6). The negative value of the
3rd statistical moment designates that the distribution is negatively skewed (the tail is extended
towards lower values), indicating that both mean and median values are less than the mode in
the analyzed data set. The 4th statistical moment characterizes the strength of the outliers of the
distribution [41].
Figure 7 shows the results of statistical analysis of the spatial distributions of m22 element,
which represents the degree of residual polarization of the incident linearly polarized light
backscattered by the medium and contributes to the total depolarization parameter [see Eq. (1)].
The statistical analysis of m22 coefficient has shown similar dependencies of statistical moments.
According to the obtained results, the statistical moments of the 1st and 2nd orders of the spatial
distributions of degree of residual linear polarization do not exhibit noticeable changes, whereas
the high-order statistical moments reveal exponential changes with the AD progression (see
Fig. 7). The 3rd statistical moment of m22 [see Fig. 7(c)] is positive, which indicates that the
distribution is skewed towards higher values. This is consistent with the 3rd statistical moment
of total depolarization distribution [see Fig. 6(c)], due to the relation between m22 and total
depolarization parameter [see Eq. (1)].
As it was demonstrated in previous studies [8], due to the accumulation of Aβ plaques, the
AD-affected brain exhibits higher scattering coefficient (µs) and larger size of scattering particles.
The latter results in higher anisotropy of scattering (g) compared to normal tissues. While with the
Research Article Vol. 11, No. 8 / 1 August 2020 /Biomedical Optics Express 4516
Fig. 7. Statistical moments of the 1st- 4thorders characterizing the spatial distributions of
m22 element of MM measured from FFPE mouse brain with AD (50 to 200 days) at 450 nm:
(a) mean, (b) standard deviation, (c) skewness, (d) kurtosis. Red, solid lines show fitting
functions: linear in (a, b), exponential in (c, d).
AD progression, both µs and g grow, their changes compensate each other in terms of variations
of the reduced scattering coefficient µs ′ = µs(1 − g) [42]. Thus, as µs ′ of the bulk brain tissue
remains nearly unchanged [8], the impact of structural alterations, associated with accumulation
of Aβ plaques, is not clearly observed by 1st and 2nd statistical moments of spatial distributions
of total depolarization, as well as by m22 [see Figs. 6(a), 6(b), 7(a), 7(b)]. In addition, the lack
of changes in the values of 1st and 2nd statistical moments is arguably conditioned by the large
variability of optical properties of different brain areas that are affected differently by the Aβ
plaques deposition [8].
The exponential changes in the 3rd statistical moment indicate that the distributions of total
depolarization and depolarization of linearly polarized light (linear (horizontal) depolarization,
∆LH= 1 - |m22| [43]) become more skewed towards lower values with the later AD stage. The
exponential grow of the 4th statistical moment indicates that with the AD progression, the
distributions of total and linear depolarization have more strength in the outliers or become
“heavy-tailed”. The changes in high-order statistical moments are conditioned by the structural
malformations of the AD brain tissue, tending to enhance the effective scattering cross-section in
the tissue due to increase in the size of scattering particles [8], which, in turn, influences the
scattering phase function. Therefore, with the AD progression, the scattering of light becomes
anisotropic (Mie-like scattering), and the angular dependence of scattering is enhanced [42,44].
Moreover, the increase of the spatial inhomogeneity of AD-affected brain tissue contributes to
the irregularity of the scattering phase function. The angular non-uniformity of the scattering
phase function leads to the higher extremity of deviations of resultant photon trajectories in the
tissue. Due to the different number of scattering events associated with different pathlengths of
photons in the tissue, the degree of polarization of emerging photons is reduced to the different
extent [44]. These phenomena make the distributions of depolarization irregular showing lower
symmetry with respect to the central peak (i.e. higher absolute value of skewness) and lead to
the greater extremity of deviations of values of total and linear depolarization with respect to the
mean value (i.e. higher kurtosis). The observed behavior of high-order statistical moments could
be used as a marker of the β-amyloidosis severity.
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5. Summary and conclusions
We demonstrate the possibility to perform screening for amyloid deposits of mouse brain tissue
embedded in FFPE block at different stages of AD using wide-field multi-spectral MM imaging
polarimetry. In the current study, the MM images of 21 FFPE samples of mouse brain tissue at
different stages of AD were acquired at 450-550 nm wavelengths. By analyzing the obtained
multispectral MM images and corresponding imaging results acquired with a hyperspectral
camera, we have identified that the wavelength range around 450 nm is the most sensitive to
the brain tissue structure. Moreover, the particular elements of MM, which contain valuable
information on the structural alterations in the tissue, were identified and analyzed. With the
help of statistical analysis of the obtained results, we have found exponential dependencies of
the high-order statistical moments of total and linear depolarization from the growing structural
alterations associated with AD progression, namely, accumulation of Aβ plaques. This effect is
conditioned by the increase of the anisotropy of light scattering due to increase of the size of
the scattering cross-section in tissue. The obtained dependencies demonstrate that high-order
statistical moments of total and linear depolarization could be used as sensitive markers of the
growing presence of Aβ plaques. The introduced label-free, contact-free approach shows of a
potential to improve the existing practice of protein aggregate screening in AD diagnostics in
terms of time and cost efficiency by using FFPE blocks for the analysis without the need to slice
and stain the tissue. The method could also be useful for screening of optic active aggregated
proteins (e.g. prion protein) in other diseases that are highly infectious, such as Creutzfeldt-Jakob
disease.
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